Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
Bristol Myers Squibb on Thursday said it King88bet Login will slash $2 billion in costs by the end of 2027, expanding its ongoing cost-savings usaha to chart a path toward long-term growth. Bristol Myers said savings will be driven by organizational changes and usahas to streamline operations, and will allow the company to invest in new science and drug brands expected to deliver growth. The pharmaceutical giant still plans to cut $1.5 billion in costs by the end of 2025 and funnel that money into drug development. It first announced those cuts in April, and expanded on them with Thursday's announcement. The company is preparing to offset the King88bet Slot loss in revenue from top-selling treatments slated to lose exclusivity on the pasar, including its blockbuster blood thinner Eliquis and cancer immunotherapy Opdivo. Also on Thursday, Bristol Myers Squibb issued full-year 2025 guidance that fell short of Wall Street's expectatio...